Immune mechanisms in interstitial lung diseases

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 55, Issue 12, 2000, Pages 1103-1120

  Semenzato, G ^a,b   Adami, F ^a   Maschio, N ^a   Agostini, C ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; INTERSTITIAL LUNG DISEASE; LEUKOCYTE; LUNG ALVEOLITIS; LUNG ALVEOLUS MACROPHAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ALVEOLITIS, EXTRINSIC ALLERGIC; CD4-CD8 RATIO; CHEMOKINES; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPETENCE; LUNG; LUNG DISEASES, INTERSTITIAL; MACROPHAGES, ALVEOLAR; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 0033773669     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.00127.x     Document Type: Review

References (152)

1. Pulmonary immune cells in health and disease: Lymphocytes
2. Lung lymphocytes: Origin, biological functions, and laboratory techniques for their study in immune-mediated pulmonary disorders
3. Epithelioid cell granulomatosis of the lung: New insights and concepts
4. Immunology of idiopathic pulmonary fibrosis
5. Immune effector cells in idiopathic pulmonary fibrosis
6. Lymphocyte dynamics in the pulmonary microenvironment: Implications for the pathophysiology of pulmonary sarcoidosis
7. Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury
8. Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury
9. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis
10. Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients
11. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis
12. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome
13. Pulmonary macrophages
14. Extensive surface phenotyping of alveolar macrophages in interstitial lung disease
15. Pulmonary alveolar macrophages in patients with sarcoidosis and hypersensitivity pneumonitis: Characterization by monoclonal antibodies
16. Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity
17. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells
18. Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations
19. Cells and cytokines involved in the pathogenesis of sarcoidosis
20. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process
21. CD8 T-cell infiltration in extravascular tissues of patients with human immunodeficiency virus infection. Interleukin-15 upmodulates costimulatory pathways involved in the antigen-presenting cells-T-cell interaction
22. Immunohistochemical localization of B7 costimulating molecules and major histocompatibility complex class II antigen in pulmonary sarcoidosis
23. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L
24. Blockade of T cell costimulation by CTLA4-Ig inhibits lung inflammation in murine hypersensitivity pneumonitis
25. Pulmonary immune cells in health and disease: Polymorphonuclear neutrophils
26. The role of cytokines and adhesion molecules in the development of inflammatory injury
27. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fbrosis and pulmonary sarcoidosis
28. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects
29. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
30. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant
31. IL-4 and IL-13 stimulate human bronchial epithelial cells to release IL-8
32. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
33. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice
34. A promoter recruitment mechanism for tumor necrosis factor-alpha-induced interleukin-8 transcription in type II pulmonary epithelial cells. Dependence on nuclear abundance of Re1 A, NF-kappaB1, and c-Re1 transcription factors
35. Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease
36. Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models
37. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
38. Cytokines in sarcoidosis
39. Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and betachain subunits: Association of IL-2 binding with secretion of the monocyte chemoattractant protein-1
40. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts
41. Interleukin-4-producing cells in idiopathic pulmonary fibrosis: An immunohistochemical study
42. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice
43. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness
44. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease
45. Polarized type 1 cytokine profile in bronchoalveolar lavage T cells of patients with hypersensitivity pneumonitis
46. Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung
47. Regulation of acute lung inflammatory injury by endogenous IL-13
48. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
49. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis
50. Cytokine patterns in tuberculous and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response
51. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis
52. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions
53. The Th1/Th2 paradigm
54. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)
55. HIV and pulmonary immune responses
56. Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases
57. Interleukin-1 (IL-1) is an important cytokine in granulomatous alveolitis
58. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease
59. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure
60. Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montreal Lung Transplantation Group
61. Secretion and mRNA expression of TNF alpha and IL-6 in the lungs of pneumoconiosis patients
62. Interleukin-6 in mouse hypersensitivity pneumonitis: Changes in lung free cells following depletion of endogenous IL-6 or direct administration of IL-6
63. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease
64. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis
65. Interleukin 6 secretion by monocytes and alveolar macrophages in systemic sclerosis with lung involvement
66. A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene
67. Interleukin 12 at the site of disease in tuberculosis
68. Increased expression of IL-12 receptor mRNA in active pulmonary tuberculosis and sarcoidosis
69. Increased numbers of interleukin-12-producing cells in human tuberculosis
70. IL-12 modulates expression of hypersensitivity pneumonitis
71. Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo
72. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases
73. Airway epithelium expresses interleukin-18
74. Proliferation, macrophage colony-stimulating factor, and macrophage colony-stimulating factor-receptor expression of alveolar macrophages in active sarcoidosis
75. Expression of granulocytemacrophage colony-stimulating factor mRNA by inflammatory cells in the sarcoid lung
76. Synthesis and release of granulocyte-macrophage colony stimulating factor by alveolar macrophages of patients with sarcoidosis
77. Release of granulocytemacrophage colony-stimulating factor by alveolar macrophages in the lung of HW-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation
78. Overexpression of transforming growth factor-alpha and epidermal growth factor-receptor in idiopathic pulmonary fibrosis
79. Cytokines and pulmonary fibrosis
80. Transforming growth factor-beta (TGF-beta) in silicosis
81. Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages
82. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factoralpha and interleukin-6 but not interleukin-1 beta
83. Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease
84. Increased expression of apoptosis signalling receptors by alveolar macrophages in sarcoidosis
85. Elevated levels of soluble TNF receptors in bronchoalveolar lavage fluid in extrinsic allergic alveolitis
86. Cell apoptosis and granuloma lung diseases
87. Chemokines and leukocyte traffic
88. Chemokines - Chemotactic cytokines that mediate inflammation
89. International Union of Pharmacology XXII. Nomenclature for chemokine receptors
90. Chemotactic cytokines: From the molecular level to clinical use
91. Measurement of serum monocyte chemoattractant protein-1 and its clinical application for estimating the activity of granuloma formation in sarcoidosis
92. Expression of RANTES by bronchoalveolar lavage cells in nonsmoking patients with interstitial lung diseases
93. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis
94. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: Involvement of macrophages and endothelial cells
95. CXC chemokines IP-10 and Mig are expressed and direct migration of pulmonary CD8+/CXCR3+ T cells in the lung of patients with HIV infection and T-cell alveolitis
96. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells
97. Expression of monocyte chemoattractant protein-1 (MCP-1) by rat alveolar macrophages during chronic lung injury
98. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury
99. Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis
100. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases
101. Role of IL-16 in delayed-type hypersensitivity reaction
102. Interleukin 16 and its function as a CD4 ligand
103. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro
104. CD13/aminopeptidase N, a novel chemoattractant for T lymphocytes in pulmonary sarcoidosis
105. A role for C-C chemokines in fibrotic lung disease
106. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders
107. Immunological, clinical and molecular aspects of sarcoidosis
108. Sarcoidosis
109. Altered expression of natural killer cell inhibitory receptors (KIRs) on T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients
110. Selection of T lymphocytes bearing limited TCR-Vbeta regions in the lung of hypersensitivity pneumonitis and sarcoidosis
111. T-cell receptor genes in sarcoidosis
112. Restricted V alpha 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3
113. Selection of Valpha 2.3 cells in the lung of patients with sarcoidosis
114. T4/T8 ratio in bronchoalveolar lavage fluid: Sensitivity and specificity for the diagnosis of sarcoidosis
115. CD4/CD8 ratios in bronchoalveolar lavage fluid: Of value for diagnosing sarcoidosis?
116. CD8 alveolitis in sarcoidosis: Incidence, phenotypic characteristics, and clinical features
117. Soluble CD14 is increased in bronchoalveolar lavage of active sarcoidosis and correlates with alveolar macrophage membrane-bound CD14
118. Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis
119. Chronic beryllium disease
120. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations
121. Immunopathology of tuberculosis: Roles of macrophages and monocytes
122. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection
123. T cell response to Mycobacterium tuberculosis
124. Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis
125. Cytokines and tuberculosis
126. Macrophage activation: Lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha
127. Hypersensitivity pneumonitis
128. Extrinsic allergic alveolitis
129. Longitudinal study of alveolitis in hypersensitivity pneumonitis patients: An immunologic evaluation
130. Summer-type hypersensitivity pneumonitis. T-cell receptor V gene usage in BALF T-cells from 3 cases in one family
131. Prognostic significance of bronchoalveolar lymphocytosis in farmer's lung
132. AIDS virus-specific cytotoxic T lymphocytes in lung disorders
133. Skewing of the T-cell receptor repertoire in the lung of patients with HIV-1 infection
134. HIV load in highly purified CD8+ T cells retrieved from pulmonary and blood compartments
135. CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1
136. Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection
137. Cytotoxic events taking place in the lung of patients with HIV-1 infection. Evidence of an intrinsic defect of the major histocompatibility complex-unrestricted killing partially restored by the incubation with rIL-2
138. Gamma delta T cell receptor subsets in the lung of patients with HIV-1 infection
139. Alveolar CD8+ CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions
140. Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals
141. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients
142. Lung transplantation
143. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients
144. Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantation
145. Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans
146. Connective tissue diseases
147. Bronchoalveolar lavage in rheumatoid arthritis
148. Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE)
149. Bronchoalveolar lavage analysis of interstitial lung disease in CREST syndrome
150. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung
151. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings
152. Alveolitis correlates with clinical pulmonary involvement in primary Sjogren's syndrome